EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Preconception thyroid function optimization and pregnancy outcomes in women with recurrent pregnancy loss: a real-world cohort study

Heze Xu iD, Zhijiao Wang, Yijia Liu, Shanwei Xing, Hang Zhen, Jiapo Li, Chong Qiao

Endocrine Connections · 01.07.2026 · 15 (7)

DOI: 10.1530/ec-26-0215 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Endocrine Connections, online erschienen am 07.07.2026. Verfasst von Heze Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shengjing Hospital, China Medical University , Shenyang, Liaoning Province, China. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The management of subclinical hypothyroidism with thyroid-stimulating hormone (TSH) levels between 2.5 and 4.0 mIU/L in women with recurrent pregnancy loss (RPL) remains controversial, as guidelines derived from general populations conflict. While a recent randomized trial confirmed the benefit of initiating levothyroxine (LT4) during early pregnancy, whether a more proactive strategy of preconception thyroid optimization improves outcomes in this high-risk group remains unknown.

Methods

We conducted a retrospective cohort analysis of 896 women with RPL and elevated TSH (2.5–4.0 mIU/L) during pre-pregnancy, from the Recurrent Pregnancy Loss Cohort Study. Based on clinical records, participants were categorized into two groups: treated group (n = 636) and untreated group (n = 260). The primary outcome was miscarriage. Associations were assessed using Firth’s penalized-likelihood regression to address small-sample bias, with propensity score matching as a sensitivity analysis.

Results

After adjustment for antiphospholipid syndrome, degree of education, gravidity, and parity, LT4 treatment was associated with a significantly lower risk of miscarriage (adjusted odds ratio (aOR) = 0.33; 95% CI: 0.20, 0.54; P < 0.001). A reduced risk was also observed for threatened abortion (aOR = 0.49; 95% CI: 0.35, 0.71; P < 0.001). Results were robust in the propensity score-matched analysis.

Conclusion

In women with RPL and elevated TSH (2.5–4.0 mIU/L), a clinical care pathway involving preconception LT4 treatment was significantly associated with a reduced risk of miscarriage. This finding provides real-world evidence supporting the potential value of proactive preconception thyroid optimization in RPL, highlighting it as a priority strategy worthy of prospective investigation versus post-conception treatment initiation.

Schlagwörter

Stichwörter der Autor:innen

levothyroxinemiscarriagepregnancy lossrecurrent pregnancy losssubclinical hypothyroidism

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Shengjing Hospital, China Medical University , Shenyang, Liaoning Province, China.
  • Key Laboratory of Maternal-Fetal Medicine of Liaoning Province , Shenyang, Liaoning, China.
  • Research Center of China Medical University Birth Cohort , Shenyang, Liaoning Province, China.

ORCID-Profile: Heze Xu

Zitieren

APA

Xu, H., Wang, Z., Liu, Y., Xing, S., Zhen, H., Li, J., & Qiao, C. (2026). Preconception thyroid function optimization and pregnancy outcomes in women with recurrent pregnancy loss: a real-world cohort study. Endocrine Connections, 15(7). https://doi.org/10.1530/ec-26-0215

Vancouver

Xu H, Wang Z, Liu Y, Xing S, Zhen H, Li J, et al. Preconception thyroid function optimization and pregnancy outcomes in women with recurrent pregnancy loss: a real-world cohort study. Endocrine Connections. 2026;15(7). doi:10.1530/ec-26-0215

BibTeX
@article{Xu2026,
  author = {Xu, Heze and Wang, Zhijiao and Liu, Yijia and Xing, Shanwei and Zhen, Hang and Li, Jiapo and Qiao, Chong},
  title = {Preconception thyroid function optimization and pregnancy outcomes in women with recurrent pregnancy loss: a real-world cohort study},
  journal = {Endocrine Connections},
  year = {2026},
  volume = {15},
  number = {7},
  doi = {10.1530/ec-26-0215}
}
Kostenlos starten →